Sexual dimorphism in MIR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity

International Journal of Obesity

Volumn 39, Issue 8, 2015, Pages 1274-1281

  Muralimanoharan, S ^a   Guo, C ^a   Myatt, L ^a   Maloyan, A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 210; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MIRN210 MICRORNA, HUMAN;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CONTROLLED STUDY; CYTOTROPHOBLAST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; FETUS; FETUS WEIGHT; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MALE; MATERNAL AGE; MATERNAL OBESITY; MITOCHONDRIAL RESPIRATION; OXYGEN CONSUMPTION; PLACENTA; PLACENTA DISORDER; PLACENTA WEIGHT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEX DIFFERENCE; SYNCYTIOTROPHOBLAST; TROPHOBLAST; UTERUS; CELL HYPOXIA; COMPLICATION; FETUS DEVELOPMENT; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; METABOLISM; MITOCHONDRION; OBESITY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PROTEIN TRANSPORT; SEXUAL DEVELOPMENT; TERM BIRTH; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CELL HYPOXIA; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY, INNATE; INFLAMMATION; MICRORNAS; MITOCHONDRIA; NF-KAPPA B; OBESITY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANT WOMEN; PROTEIN TRANSPORT; SEX CHARACTERISTICS; TERM BIRTH;

EID: 84938751793     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.45     Document Type: Article

References (60)

1. Zhu MJ, Du M, Nathanielsz PW, Ford SP. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta 2010; 31: 387-391
2. Okereke NC, Huston-Presley L, Amini SB, Kalhan S, Catalano PM. Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab 2004; 287: E472-E479
3. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999; 180: 903-916
4. Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin North Am 2009; 36: 285-300
5. Reece EA. Obesity, diabetes, and links to congenital defects: a review of the evidence and recommendations for intervention. J Matern Fetal Neonatal Med 2008; 21: 173-180
6. Vasudevan C, Renfrew M, McGuire W. Fetal and perinatal consequences of maternal obesity. Arch Dis Child Fetal Neonatal Ed 2011; 96: F378-F382
7. Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol 2007; 197: 223-228
8. Frias AE, Morgan TK, Evans AE, Rasanen J, Oh KY, Thornburg KL et al. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology 2011; 152: 2456-2464
9. Rogers LK, Velten M. Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease. Life Sci 2011; 89: 417-421
10. Jansson T, Powell TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 2007; 113: 1-13
11. Burton GJ, Fowden AL. Review: the placenta and developmental programming: balancing fetal nutrient demands with maternal resource allocation. Placenta 2012; 33: S23-S27
12. Myatt L. Placental adaptive responses and fetal programming. J Physiol 2006; 572: 25-30
13. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004; 122: 369-382
14. Roberts VH, Smith J, McLea SA, Heizer AB, Richardson JL, Myatt L. Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta 2009; 30: 169-175
15. Myatt L, Roberts VH. Placental mechanisms and developmental origins of health and disease. In: Gluckman P, Hanson M (eds). Developmental Origins of Health and Disease. Cambridge University Press: Cambridge, UK, 2006. pp 130-142
16. Oliva K, Barker G, Riley C, Bailey MJ, Permezel M, Rice GE et al. The effect of pre-existing maternal obesity on the placental proteome: two-dimensional difference gel electrophoresis coupled with mass spectrometry. J Mol Endocrinol 2012; 48: 139-149
17. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010; 11: 252-263
18. Avissar-Whiting M, Veiga KR, Uhl KM, Maccani MA, Gagne LA, Moen EL et al. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol 2010; 29: 401-406
19. Maccani MA, Avissar-Whiting M, Banister CE, McGonnigal B, Padbury JF, Marsit CJ. Maternal cigarette smoking during pregnancy is associated with down regulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics 2010; 5: 583-589
20. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 2007; 196: 261 e1-261 e6
21. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K, Williams MA. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2011; 204: 178 e12-178 e21
22. Maccani MA, Padbury JF, Marsit CJ. miR-16 and miR-21 expression in the placenta is associated with fetal growth. PLoS One 2011; 6: e21210
23. Chan YC, Banerjee J, Choi SY, Sen CK. miR-210: the master hypoxamir. Microcirculation 2011; 19: 215-223
24. Nakada C, Tsukamoto Y, Matsuura K, Nguyen TL, Hijiya N, Uchida T et al. Overexpression of miR-210, a downstream target of HIF1alpha, causes centrosome amplification in renal carcinoma cells. J Pathol 2011; 224: 280-288
25. Devlin C, Greco S, Martelli F, Ivan M. miR-210: more than a silent player in hypoxia. IUBMB Life 2011; 63: 94-100
26. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK et al. Hypoxiainducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 2009; 35: 856-867
27. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, Myatt L. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 2012; 33: 816-823
28. Mele J, Muralimanoharan S, Maloyan A, Myatt L. Impaired mitochondrial function in human placenta with increased maternal adiposity. Am J Physiol Endocrinol Metab 2014; 307: E419-E425
29. Bax CM, Ryder TA, Mobberley MA, Tyms AS, Taylor DL, Bloxam DL. Ultrastructural changes and immunocytochemical analysis of human placental trophoblast during short-term culture. Placenta 1989; 10: 179-194
30. Maloyan A, Mele J, Muralimanohara B, Myatt L. Measurement of mitochondrial respiration in trophoblast culture. Placenta 2012; 33: 456-458
31. Magenta A, Greco S, Gaetano C, Martelli F. Oxidative stress and microRNAs in vascular diseases. Int J Mol Sci 2013; 14: 17319-17346
32. Naeye RL. Maternal body weight and pregnancy outcome. Am J Clin Nutr 1990; 52: 273-279
33. Schmatz M, Madan J, Marino T, Davis J. Maternal obesity: the interplay between inflammation, mother and fetus. J Perinatol 2010; 30: 441-446
34. Catalano PM. Increasing maternal obesity and weight gain during pregnancy: the obstetric problems of plentitude. Obstet Gynecol 2007; 110: 743-744
35. King JC. Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr 2006; 26: 271-291
36. Drake AJ, Reynolds RM. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction 2010; 140: 387-398
37. Myatt L. Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010; 31: S66-S69
38. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006; 83: 461S-465S
39. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 2009; 10: 273-284
40. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007; 116: 258-267
41. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008; 39: 959-966
42. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G et al. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010; 116: 2148-2158
43. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 2010; 5: e10345
44. Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li L et al. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med 2012; 16: 249-259
45. Anton L, Olarerin-George AO, Schwartz N, Srinivas S, Bastek J, Hogenesch JB et al. miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol 2013; 183: 1437-1445
46. Mele J, Muralimanoharan S, Maloyan A, Myatt L. Impaired mitochondrial function in human placenta with increased maternal adiposity. Am J Physiol Endocrinol Metab 2014; 307: E419-E425
47. Sampey BP, Freemerman AJ, Zhang J, Kuan PF, Galanko JA, O'Connell TM et al. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One 2012; 7: e38812
48. Li ZL, Woollard JR, Ebrahimi B, Crane JA, Jordan KL, Lerman A et al. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis. Arterioscler Thromb Vasc Biol 2012; 32: 1132-1141
49. Nesca V, Guay C, Jacovetti C, Menoud V, Peyot ML, Laybutt DR et al. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 2013; 56: 2203-2212
50. Perri R, Nares S, Zhang S, Barros SP, Offenbacher S. MicroRNA modulation in obesity and periodontitis. J Dent Res 2012; 91: 33-38
51. Bye A, Rosjo H, Aspenes ST, Condorelli G, Omland T, Wisloff U. Circulating microRNAs and aerobic fitness-\-The HUNT-Study. PLoS One 2013; 8: e57496
52. Saben J, Lindsey F, Zhong Y, Thakali K, Badger TM, Andres A et al. Maternal obesity is associated with a lipotoxic placental environment. Placenta 2014; 35: 171-177
53. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18: 621-663
54. Vina J, Borras C, Gambini J, Sastre J, Pallardo FV. Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowledge Environ 2005; 2005: pe17
55. Ciaudo C, Servant N, Cognat V, Sarazin A, Kieffer E, Viville S et al. Highly dynamic and sex-specific expression of microRNAs during early ES cell differentiation. PLoS Genet 2009; 5: e1000620
56. Mujahid S, Logvinenko T, Volpe MV, Nielsen HC. miRNA regulated pathways in late stage murine lung development. BMC. Dev Biol 2013; 13: 13
57. Morgan CP, Bale TL. Early prenatal stress epigenetically programs dysmasculinization in second-generation offspring via the paternal lineage. J Neurosci 2011; 31: 11748-11755
58. Zambon A, Pauletto P, Crepaldi G. Review article: the metabolic syndrome-A chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther 2005; 22: 20-23
59. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech 2009; 2: 231-237
60. Wang YT, Tsai PC, Liao YC, Hsu CY, Juo SH. Circulating microRNAs have a sex-specific association with metabolic syndrome. J Biomed Sci 2013; 20: 72